HOPMAN MARK (Chief Commercial Officer) sold 3.9% of their position (5.33K shares) of BETA BIONICS, INC. on the open market
Open‑market sale worth $67.2K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 6/3/2026ACC: 0002048497-26-000007
Officer· Chief Commercial Officer
Since Mar 2026
-5.33K
Net shares
Net seller
$67.2K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
5.33K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−5.33K
Price / share
$12.61
Trade value
$67.18K
% of position
3.9%
6/2/2026
136.22K→130.89K
Total
Net shares
−5.33K
Net value
-$67.18K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 6/2/2026 | S · Sale | −5.33K | $12.61 | $67.18K | 3.9% | 136.22K | 130.89K |
| Total | −5.33K | -$67.18K | ||||||
Derivative Transactions0
No derivative transactions reported